77. Growth hormone secreting pituitary adenoma Clinical trials / Disease details

Clinical trial : 1 / Drug : 1 - (DrugBank : 1) / Drug target genes : 2 - Drug target pathways : 20

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1800017714	2019-01-01	2018-08-10	The Effect and safety Assessment of MetforminTherapy in Growth Hormone-secreting Pituitary Adenoma ( ...	The Effect and safety Assessment of MetforminTherapy in Growth Hormone-secreting Pituitary Adenoma ( ...	Growth Hormone-secreting Pituitary Adenoma (GH-PA)	Bromocentine Group:bromocentine mesylate tablet, starting dose is 0.625-1.25mg/d and the weekly incr ...	Department of Endocrinology, Second Affiliated Hospital of Army Medical University	NULL	Pending	18	70	Both	Bromocentine Group:10;Bromocentine and Metformin Group:10;Gamma Knife Radiosurgery Group:10;Gamma Knife Radiosurgery and Metformin Group:10;		China

First Previous1Next Last